BridgeBio Pharma, Inc. - 8-K Filing

BridgeBio Pharma announced an agreement with the U.S. government to expand access and affordability of critical medicines for rare genetic diseases. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $BBIO

Read the full article at SEC EDGAR

More Regulatory news